Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,067 | Dovepress* | 4,916+ | 1,136 | 6,052 | |
| PubMed Central* | 1,151 | 295 | 1,446 | ||
| Totals | 6,067 | 1,431 | 7,498 | ||
| *Since 25 March 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar